<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="13237">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01854307</url>
  </required_header>
  <id_info>
    <org_study_id>2012/1475/REK vest</org_study_id>
    <nct_id>NCT01854307</nct_id>
  </id_info>
  <brief_title>The Influence of Pneumoperitoneum on Minimal Invasive Cardiac Output Measurements</brief_title>
  <official_title>The Influence of Pneumoperitoneum on Minimal Invasive Cardiac Output Measurements</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Haukeland University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Haukeland University Hospital</source>
  <oversight_info>
    <authority>Norway: Regional Ethics Commitee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Perioperative goal directed fluid therapy may reduce complication rate after surgery.
      Minimal invasive cardiac output monitoring is a key method to guide fluid therapy. More
      operations are being performed by keyhole surgery (laparoscopy). For laparoscopy, the
      abdomen is filled with carbon dioxide. Increased pressure in the abdomen may influence
      minimal cardiac output monitoring, therefore minimal cardiac output monitoring is not
      recommended during laparoscopy. This study aims to validate minimal cardiac output
      monitoring during laparoscopy and therefore facilitate for goal directed fluid therapy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2013</start_date>
  <primary_completion_date type="Anticipated">October 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research</study_design>
  <primary_outcome>
    <measure>Change of stroke volume variation and pulse pressure variation during pneumoperitoneum</measure>
    <time_frame>peroperative</time_frame>
    <safety_issue>No</safety_issue>
    <description>Change in PPV/SVV(LiDCO), PPV(Philips) and SVV/CO(TEE) in percent before and after pneumoperitoneum.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Difference in measurements from different methods of minimal cardiac output monitoring.</measure>
    <time_frame>peroperative</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of fluid bolus under pneumoperitoneum (responder vs. non-responder)</measure>
    <time_frame>peroperative</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Pneumoperitoneum</condition>
  <arm_group>
    <arm_group_label>Pneumoperitoneum and SVV/PPV</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pneumoperitoneum and SVV/PPV</intervention_name>
    <arm_group_label>Pneumoperitoneum and SVV/PPV</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  all patients &gt;18 years scheduled for robot-assisted prostatectomy

          -  able to give informed consent

        Exclusion Criteria:

          -  Patient with atrial fibrillation or other non-regular rhythm.

          -  Severe aorta/mitral stenosis

          -  Not able to give informed consent
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Haukeland University Hospital</name>
      <address>
        <city>Bergen</city>
        <zip>5021</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ib Jammer</last_name>
      <email>ib.jammer@helse-bergen.no</email>
    </contact>
    <investigator>
      <last_name>Elin Aakre, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gro Ã˜stgaard, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ole Kristian Ulveseth, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <lastchanged_date>May 14, 2013</lastchanged_date>
  <firstreceived_date>May 13, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Haukeland University Hospital</investigator_affiliation>
    <investigator_full_name>Ib Jammer</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Difference of</keyword>
  <keyword>measurements</keyword>
  <keyword>before and after</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>No</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pneumoperitoneum</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
